Skip to main content
. 2006 Dec;21(12):1242–1247. doi: 10.1111/j.1525-1497.2006.00590.x

FIGURE 3.

FIGURE 3

Hazard ratios with 1-year mortality of ARB use compared with ACEI use after myocardial infarction. ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin-II-receptor blocker; CHF, previous diagnosis of congestive heart failure; New Users, no ACEI or ARB use in 365 days before admission for myocardial infarction. ARB, reference group.